NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 8 filers reported holding NOVELION THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $2,572,000 | +14.4% | 3,674,185 | +18.5% | 0.02% | +9.1% |
Q3 2019 | $2,248,000 | +1.8% | 3,100,931 | +9.5% | 0.02% | 0.0% |
Q2 2019 | $2,209,000 | -25.8% | 2,831,555 | +16.9% | 0.02% | -33.3% |
Q1 2019 | $2,978,000 | +49.6% | 2,421,259 | +2.2% | 0.03% | +37.5% |
Q4 2018 | $1,990,000 | -69.4% | 2,368,819 | +7.9% | 0.02% | -67.6% |
Q3 2018 | $6,497,000 | -19.6% | 2,195,063 | 0.0% | 0.07% | -26.7% |
Q2 2018 | $8,078,000 | +5.1% | 2,195,063 | 0.0% | 0.10% | -7.3% |
Q1 2018 | $7,683,000 | +12.3% | 2,195,063 | +0.1% | 0.11% | +11.2% |
Q4 2017 | $6,839,000 | -6.3% | 2,191,913 | +111.1% | 0.10% | -10.1% |
Q3 2017 | $7,301,000 | – | 1,038,566 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 1,313,387 | $4,833,000 | 13.70% |
Stonepine Capital Management, LLC | 1,792,911 | $6,598,000 | 4.01% |
Broadfin Capital, LLC | 1,948,554 | $7,171,000 | 1.13% |
Sarissa Capital Management LP | 1,025,000 | $3,772,000 | 0.76% |
JW Asset Management, LLC | 315,979 | $1,163,000 | 0.74% |
Prosight Management, LP | 194,663 | $716,000 | 0.52% |
ARMISTICE CAPITAL, LLC | 1,856,000 | $6,830,000 | 0.45% |
KNOTT DAVID M | 109,184 | $402,000 | 0.15% |
EdgePoint Investment Group Inc. | 2,195,063 | $8,078,000 | 0.10% |
Yakira Capital Management, Inc. | 36,428 | $134,000 | 0.03% |